AG真人官方

Amrize Ltd (AMRZ) disclosed that director Holli C. Ladhani received a restricted stock unit award for 2,958 ordinary shares under the Amrize Ltd 2025 Omnibus Incentive Plan. The award was reported as an acquisition on 08/11/2025 at a reported price of $0 and is shown as direct beneficial ownership of 2,958 shares following the transaction. The restricted stock units vest on the earlier of the one-year anniversary of the grant date or the issuer鈥檚 next regular annual meeting of shareholders, meaning the shares may convert to ownership within that timeframe if vesting conditions are met.

Gibson Dwight Audley Konrad, identified as a director of Amrize Ltd (AMRZ), was granted 2,958 ordinary shares as a restricted stock unit award under the Amrize Ltd 2025 Omnibus Incentive Plan. The award was recorded as an acquisition at a $0 price and is held directly by the reporting person. The RSUs vest on the earlier of the one-year anniversary of the grant date or the issuer's next regular annual meeting of shareholders. Following the reported transaction, the reporting person beneficially owns 2,958 shares.

Amrize Ltd director Nicholas C Gangestad was awarded 2,958 restricted stock units (RSUs) under the Amrize Ltd 2025 Omnibus Incentive Plan. The award is reported as an acquisition that results in 2,958 ordinary shares beneficially owned directly following the transaction and is recorded at a $0 price.

The RSUs vest on the earlier of the one鈥憏ear anniversary of the grant date and the issuer's next regular annual meeting of shareholders, creating a time鈥慴ased grant that converts to ordinary shares on vesting. No derivative securities were reported in this filing and no additional cash or material financial terms beyond the vesting condition and share count are disclosed.

Amrize Ltd (AMRZ) director Drew Theresa J was granted 2,958 restricted stock units (RSUs) under the Amrize Ltd 2025 Omnibus Incentive Plan, recorded as an acquisition on 08/11/2025. The award was issued at a $0 price and is reported as 2,958 ordinary shares beneficially owned by the reporting person following the transaction.

The RSUs vest on the earlier of the one-year anniversary of the grant and the issuer's next regular annual meeting of shareholders, creating alignment between the director and shareholders while representing a routine equity-compensation award that is modest in absolute size relative to typical market capitalization impacts. The Form 4 was filed by a single reporting person.

Jan Philipp Jenisch, who serves as Chairman & CEO and a director of Amrize Ltd (AMRZ), reported multiple purchases of the issuer's ordinary shares on 08/11/2025. The reporting person acquired 545,000 ordinary shares directly in several transactions priced roughly between $47.59 and $47.99. An additional 50,000 shares were acquired indirectly by the reporting persons spouse. Following these transactions, the filing shows 1,450,000 shares beneficially owned directly and 450,000 shares beneficially owned indirectly by the spouse. The prices reported reflect conversions from Swiss francs using an exchange rate of USD 1.00 = CHF 0.8084, and the filer offers to provide a full breakdown of the CHF-priced lots upon request.

Jan Philipp Jenisch, Chairman & CEO and director of Amrize Ltd (AMRZ), reported multiple purchases on 08/08/2025 totaling 500,000 ordinary shares 鈥� 100,000 acquired directly and 400,000 acquired indirectly by spouse. The trades were executed in Swiss francs at CHF 37.40鈥揅HF 38.44 and converted at the transaction-date rate (USD 1.00 = CHF 0.8086), producing reported USD prices of approximately $46.25鈥�$47.54 per share. Following these transactions the filing shows 905,000 shares beneficially owned directly and 400,000 shares beneficially owned indirectly by spouse. The Form 4 was signed by an attorney-in-fact on 08/12/2025.

James J. Gosa, who is identified as an officer (President, Building Envelope) and a director of Amrize Ltd (AMRZ), was awarded restricted stock units on 08/11/2025 under the Amrize Ltd 2025 Omnibus Incentive Plan. Two awards were reported: 36,952 RSUs that vest on March 21, 2026 and 18,687 RSUs that vest on March 21, 2027. Both grants are recorded with a price of $0.

Following these reported transactions the filing shows the reporting person beneficially owns 55,639 ordinary shares on a direct basis. The entries are presented as non-derivative security acquisitions (restricted stock unit awards) with the vesting schedule and award source explicitly stated in the explanations.

Poletti Samuel Jonas, identified as Chief Strategy & M&A Officer of Amrize Ltd (AMRZ), reported a purchase of ordinary shares on 08/08/2025. The filing shows an acquisition of 1,280 ordinary shares purchased at CHF 37.37 per share, converted at the transaction-date rate (USD 1.00 = CHF 0.8086) to a reported price of $46.22 per share. Following the transaction, the reporting person beneficially owned 3,389 ordinary shares in a direct ownership form.

The Form 4 was submitted by one reporting person and bears a signature dated 08/12/2025 by Hans Weinburger, Attorney-in-Fact. The filing explicitly discloses the currency conversion used for the transaction. No derivative transactions or additional dispositions are reported in this Form 4.

Mario Gross, Chief Supply Chain Officer of Amrize Ltd (AMRZ), reported two open-market purchases of ordinary shares. The filings show purchases of 5,000 shares on 08/08/2025 and 2,600 shares on 08/11/2025, executed in Swiss francs and converted to U.S. dollars at the stated exchange rates. The reported USD-equivalent prices were $46.78 and $47.75 per share. After these transactions Gross beneficially owned 20,232 shares. The Form 4 discloses the transaction codes as purchases and includes conversion details for transparency.

The filing contains only non-derivative purchases and a manual signature by an attorney-in-fact; no options, dispositions, or other compensatory awards are reported.